miR-199 can downregulate the expression of the mTOR signaling pathway to enhance the sensitivity of HCC to DOX.miR-199 also targets the AGAP2 gene and suppresses its expression, enhancing the sensitivity of glioma cells to temozolomide and inhibiting tumor progression. This evidence concerns the gene AGAP2 and central nervous system cancer.